Terramed Alliance News Safe To Treat HER2-positive Breast Cancer
Terramed Alliance News Safe To Treat HER2-positive Breast Cancer Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)–typically used in combination with chemotherapy. However, a new study by researchers at Fox Chase Cancer Center reports that it may be safe to treat these patients with both Trastuzumab [...]
